ID   Panc 01.28
AC   CVCL_7666
SY   Panc 1.28; Panc1.28
DR   ATCC; CRL-2548
DR   BioSample; SAMN03471609
DR   BioSample; SAMN06481121
DR   Wikidata; Q54937500
RX   PubMed=9612602;
RX   PubMed=18000365;
WW   https://iclac.org/wp-content/uploads/Cross-Contaminations_v12_distribution.xlsx
CC   Problematic cell line: Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00519.
CC   Discontinued: ATCC; CRL-2548; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7664 ! Panc 04.21
OI   CVCL_7665 ! Panc 06.03
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
RX   PubMed=9612602;
RA   Jaffee E.M., Schutte M., Gossett J., Morsberger L.A., Adler A.J.,
RA   Thomas M., Greten T.F., Hruban R.H., Yeo C.J., Griffin C.A.;
RT   "Development and characterization of a cytokine-secreting pancreatic
RT   adenocarcinoma vaccine from primary tumors for use in clinical
RT   trials.";
RL   Cancer J. Sci. Am. 4:194-203(1998).
//
RX   PubMed=18000365; DOI=10.1159/000108295;
RA   Griffin C.A., Morsberger L.A., Hawkins A.L., Haddadin M., Patel A.,
RA   Ried T., Schrock E., Perlman E.J., Jaffee E.M.;
RT   "Molecular cytogenetic characterization of pancreas cancer cell lines
RT   reveals high complexity chromosomal alterations.";
RL   Cytogenet. Genome Res. 118:148-156(2007).
//